| Date & Time | 3 October 2023 |
|---|---|
| Location | Barcelona, Spain |
The UnConference is the annual event to debate the future of healthcare solutions, to raise awareness, perspectives and insight on the sector’s needs and opportunities, and the best way to tackle them. This year the topic of the debate is advanced therapies.
Advanced therapies
Advanced therapy medicinal products (ATMPs) offer ground-breaking therapeutic possibilities such as the treatment of previously incurable diseases or conditions. Due to the increase in the burden of chronic diseases, research and development of new therapies nowadays plays an important role in the pharmaceutical and biotech industry. Classic treatments have a significant effect on part of the population, but unfortunately not for every patient, this is one of the main reasons for further development of reliable, verified, and personalised medicines.
To drive the previous aim improved frameworks and value chains need the implementation of an ATMP common strategy. An endeavour that must be undertaken altogether by public and private entities, to avoid a shortage of development and manufacturing that will drive inequalities in the health level of our population. Leverages to achieve it should translate scientific progress into available medical products, promotion of investment and funding, and better competitiveness of our companies with improved market access and regulatory pathway.
The above-mentioned is crucial to increase the opportunity for patients to be treated with novel therapies and ensure technological sovereignty and supply.
Programme
- Welcome, Institutional Opening and Round Table (9h to 10.30h)
- What infrastructures do we need to be pioneers in advanced therapies?
- Parallel sessions: challenges to address (11h to 12.30h)
- Challenge I. What are the latest technological trends, innovations, and challenges in advanced therapies?
- Challenge II. What are investors looking for in the field of advanced therapies?
- Challenge III. How to improve market access and regulatory barriers for solutions in advanced therapies?
- Parallel sessions conclusions
- Advanced Therapies Hub: The Catalan Strategy
- Networking cocktail
Download the full programme here.
Toni Andreu, EATRIS Scientific Director, will be taking part in the roundtable “What infrastructures do we need to be pioneers in advanced therapies?”.
Learn more about this event and register here.
